Wistar receives over $12M for clinical research on opioid use in HIV-infected people

#

 

"We have uncovered a potential link between substance abuse, HIV infection and MOUDs that may determine health outcomes only if the right medication is chosen," said study leader Luis J. Montaner (CSI-1985), D.V.M., D.Phil., the Herbert Kean, M.D., Family Professor and director of the HIV-1 Immunopathogenesis Laboratory at Wistar's Vaccine & Immunotherapy Center.

To read more click here.